2seventy bio Inc (TSVT)
4.385
-0.62
(-12.30%)
USD |
NASDAQ |
May 20, 16:00
4.385
0.00 (0.00%)
After-Hours: 16:34
2seventy bio Cash and Short Term Investments (Quarterly): 181.38M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 181.38M |
| December 31, 2023 | 216.99M |
| September 30, 2023 | 250.62M |
| June 30, 2023 | 282.84M |
| March 31, 2023 | 339.93M |
| December 31, 2022 | 266.27M |
| September 30, 2022 | 323.11M |
| Date | Value |
|---|---|
| June 30, 2022 | 357.93M |
| March 31, 2022 | 377.87M |
| December 31, 2021 | 265.06M |
| September 30, 2021 | |
| June 30, 2021 | |
| December 31, 2020 | 0.00 |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
377.87M
Maximum
Mar 2022
260.18M
Average
266.27M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 9.67B |
| Johnson & Johnson | 26.22B |
| Macrogenics Inc | 184.24M |
| Akebia Therapeutics Inc | 41.96M |
| Tango Therapeutics Inc | 343.60M |